NCT05368246View on ClinicalTrials.gov

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

January 15, 2024

Study Completion Date

January 15, 2024

Conditions
Urinary IncontinenceFecal IncontinenceUrge IncontinenceNocturiaUrinary Frequency More Than Once at NightBowel Disorders FunctionalUrinary Incontinence, UrgeIncontinence, Nighttime Urinary
Interventions
DEVICE

UCon

The subjects self-administer electrical stimulation to the dorsal genital nerve (DGN) for 4 weeks using UCon

Trial Locations (3)

2730

Herlev Hospital, Herlev

5000

Odense University Hospital, Odense

8200

Aarhus University Hospital, Aarhus

Sponsors

Lead Sponsor

InnoCon Medical
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Odense University Hospital

OTHER

lead

InnoCon Medical

INDUSTRY